Meeting
2022 ASCO Quality Care Symposium
Leveraging continuing education and implementation science approaches to improve the care of patients with myeloproliferative neoplasms.
Authors
Joseph Kim
Q Synthesis LLC, Newtown, PA
Joseph Kim, Ruben A. Mesa, Cody Carter, Anthony Loc Nguyen, Eric Lau, Parthiv Sheth, Suhani Dalal, Rajesh Behl, Pablo Gutman, Linda Gracie-King, Marc David Viens, Victor Ocana
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Palliative and Supportive Care,Technology and Innovation in Quality of Care,Quality, Safety, and Implementation Science
Sub Track
Quality Improvement Research and Implementation Science
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 334)
DOI
10.1200/JCO.2022.40.28_suppl.334
Abstract #
334
Poster Bd #
D7
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
EXCEED-ET: A single-arm multicenter study to assess the efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft (P1101) in North American adults with essential thrombocythemia.
First Author: Lucia Masarova
Poster
2024 ASCO Breakthrough
Therapeutically targeting the CALR/CD47 pathway in MPN to reactivate natural immunosurveillance mechanisms within the body to enhance treatment outcomes.
First Author: Ciro Roberto Rinaldi
Poster
2024 ASCO Annual Meeting
Phase 3 randomized double-blind study evaluating selinexor, an XPO1 inhibitor, plus ruxolitinib in JAKi-naïve myelofibrosis.
First Author: John Mascarenhas
Poster
2022 ASCO Annual Meeting
Mutational landscape and clinical characterization of over 17,000 patients with myeloid malignancies using real-world data.
First Author: Taylor J. Jensen